These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11477455)

  • 21. Systemic Bcl-2 antisense oligodeoxynucleotide in combination with cisplatin cures EBV+ nasopharyngeal carcinoma xenografts in SCID mice.
    Lacy J; Loomis R; Grill S; Srimatkandada P; Carbone R; Cheng YC
    Int J Cancer; 2006 Jul; 119(2):309-16. PubMed ID: 16477627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Additional gene therapy with rAAV-wt-p53 enhanced the efficacy of cisplatin in human bladder cancer cells.
    Ruifa H; Liwei L; Binxin L; Ximing L
    Urol Int; 2006; 77(4):355-61. PubMed ID: 17135787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic efficacy of seliciclib in combination with ionizing radiation for human nasopharyngeal carcinoma.
    Hui AB; Yue S; Shi W; Alajez NM; Ito E; Green SR; Frame S; O'Sullivan B; Liu FF
    Clin Cancer Res; 2009 Jun; 15(11):3716-24. PubMed ID: 19470731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined radiation and p53 gene therapy of malignant glioma cells.
    Badie B; Goh CS; Klaver J; Herweijer H; Boothman DA
    Cancer Gene Ther; 1999; 6(2):155-62. PubMed ID: 10195882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular pathology parameters in human nasopharyngeal carcinoma.
    Shi W; Pataki I; MacMillan C; Pintilie M; Payne D; O'Sullivan B; Cummings BJ; Warde P; Liu FF
    Cancer; 2002 Apr; 94(7):1997-2006. PubMed ID: 11932902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p16 gene therapy: a potentially efficacious modality for nasopharyngeal carcinoma.
    Lee AW; Li JH; Shi W; Li A; Ng E; Liu TJ; Klamut HJ; Liu FF
    Mol Cancer Ther; 2003 Oct; 2(10):961-9. PubMed ID: 14578461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy for bladder cancer using adenoviral vector.
    Wada Y; Gotoh A; Shirakawa T; Hamada K; Kamidono S
    Mol Urol; 2001; 5(2):47-52. PubMed ID: 11690547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nutlin-3 sensitizes nasopharyngeal carcinoma cells to cisplatin-induced cytotoxicity.
    Voon YL; Ahmad M; Wong PF; Husaini R; Ng WT; Leong CO; Lane DP; Khoo AS
    Oncol Rep; 2015 Oct; 34(4):1692-700. PubMed ID: 26252575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy--Introgen, RPR/INGN 201.
    BioDrugs; 2003; 17(3):216-22. PubMed ID: 12749760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
    Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J
    J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy for human nasopharyngeal carcinoma by adenovirus-mediated transfer of human p53, GM-CSF, and B7-1 genes in a mouse xenograft tumor model.
    Ren SP; Wang L; Wang H; Wu B; Han Y; Wang LS; Wu CT
    Cancer Biother Radiopharm; 2008 Oct; 23(5):591-602. PubMed ID: 18999931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: dependence on sequencing but not p53 functional status or route of administration.
    Heise C; Lemmon M; Kirn D
    Clin Cancer Res; 2000 Dec; 6(12):4908-14. PubMed ID: 11156251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of p53 gene transfer and cisplatin in a peritonitis carcinomatosa model with p53-deficient ovarian cancer cells.
    Kigawa J; Sato S; Shimada M; Kanamori Y; Itamochi H; Terakawa N
    Gynecol Oncol; 2002 Feb; 84(2):210-5. PubMed ID: 11812076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential utility of BimS as a novel apoptotic therapeutic molecule.
    Yip KW; Li A; Li JH; Shi W; Chia MC; Rashid SA; Mocanu JD; Louie AV; Sanchez O; Huang D; Busson P; Yeh WC; Gilbert R; O'sullivan B; Gullane P; Liu FF
    Mol Ther; 2004 Sep; 10(3):533-44. PubMed ID: 15336653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenovirus-mediated p14ARF gene transfer cooperates with Ad5CMV-p53 to induce apoptosis in human cancer cells.
    Tango Y; Fujiwara T; Itoshima T; Takata Y; Katsuda K; Uno F; Ohtani S; Tani T; Roth JA; Tanaka N
    Hum Gene Ther; 2002 Jul; 13(11):1373-82. PubMed ID: 12162819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic antitumor effect of combined use of adenoviral-mediated p53 gene transfer and antisense oligodeoxynucleotide targeting clusterin gene in an androgen-independent human prostate cancer model.
    Yamanaka K; Gleave ME; Hara I; Muramaki M; Miyake H
    Mol Cancer Ther; 2005 Feb; 4(2):187-95. PubMed ID: 15713890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical study of adenoviral p53 gene therapy for esophageal cancer.
    Shimada H; Shimizu T; Ochiai T; Liu TL; Sashiyama H; Nakamura A; Matsubara H; Gunji Y; Kobayashi S; Tagawa M; Sakiyama S; Hiwasa T
    Surg Today; 2001; 31(7):597-604. PubMed ID: 11495154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo recombinant adenovirus-mediated p53 gene therapy in a syngeneic rat model for colorectal cancer.
    Baek JH; Agarwal ML; Tubbs RR; Vladisavljevic A; Tomita H; Bukowski RM; Milsom JW; Kim JM; Kwak JY
    J Korean Med Sci; 2004 Dec; 19(6):834-41. PubMed ID: 15608394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
    Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
    Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer.
    Hamada K; Alemany R; Zhang WW; Hittelman WN; Lotan R; Roth JA; Mitchell MF
    Cancer Res; 1996 Jul; 56(13):3047-54. PubMed ID: 8674061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.